Scott J. Charles, Chief Financial Officer at Aralez Pharmaceuticals Inc. (ARLZ), bought 50,000 shares at $3.49 ($175K) on 2016-05-12, disclosed to the SEC on 2016-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |